A detailed history of Gamma Investing LLC transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 27 shares of INZY stock, worth $80. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Previous 24 12.5%
Holding current value
$80
Previous $107,000 31.78%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$4.31 - $6.0 $12 - $18
3 Added 12.5%
27 $141,000
Q2 2024

Jul 02, 2024

SELL
$4.33 - $7.31 $103 - $175
-24 Reduced 50.0%
24 $107,000
Q1 2024

Apr 05, 2024

BUY
$4.14 - $7.66 $198 - $367
48 New
48 $368,000

Others Institutions Holding INZY

About Inozyme Pharma, Inc.


  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $120M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.